Scientists at the University of Glasgow have discovered a potential combination therapy for the treatment of chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in the Western world, diagnosed in more than 3,500 people in the UK each year. The research, carried out in collaboration with NHS Greater Glasgow and Clyde (NHSGGC) and
Lawyer, 34, was given just ONE WEEK to live after her doctor misdiagnosed her leukaemia as a GUM INFECTION Jenna Ostrowski, 34, was diagnosed with acute myeloid leukaemia last year Her doctor missed the signs but, luckily, she went private for tests the next day Medics said she could have been dead a week later
Chemotherapy often gets a bad reputation – mainly down to the side effects it can cause. This bad reputation can be hard to shake off. And it often stops people hearing the vast improvements that have been made in how chemotherapy is used. I can remember first learning about chemotherapy in my undergraduate pharmacology degree.
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down’s syndrome. Despite children with Down’s syndrome having around a one in 50 chance of developing acute myeloid leukaemia (AML), compared to a one
NHS set to offer cancer patients a ‘game changer’ treatment that could save THOUSANDS of lives CAR-T therapy is a new treatment for chronic lymphocytic leukaemia (CLL) The immunotherapy treatment could benefit 30,000 Britons a year Trials in the US showed it eradicated CLL in 94 per cent of patients The NHS is preparing to
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok